CoChat
Sign Up
Cited by 339

The DOI matches its Crossref record.

Challenges in the management of chronic wound infections

Falcone, Marco, De Angelis, Barbara, Pea, Federico, Scalise, Alessandro, Stefani, Stefania, Tasinato, Rolando, Zanetti, Orazio, Dalla Paola, Luca·2021·Journal of Global Antimicrobial Resistance
DOI 10.1016/j.jgar.2021.05.010
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jgar.2021.05.010

Cites

Statistics

Figures

Image 1
CC-BY-NC-ND · From the PDF
Fig. 1 Criteria to consider before culturing a chronic wound. Adapted from Cutting KF, White R. Defined and refined: criteria for identifying wound infection revisited. Br J Community Nurs 2004;9:S6-15.
Fig. 1 Criteria to consider before culturing a chronic wound. Adapted from Cutting KF, White R. Defined and refined: criteria for identifying wound infection revisited. Br J Community Nurs 2004;9:S6-15.CC-BY-NC-ND · From the PDF
Fig. 2 Indications for and types of wound debridement.
Fig. 2 Indications for and types of wound debridement.CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 88

  1. Sen, 2019, Human wounds and its burden: an updated compendium of estimates, Adv Wound Care (New Rochelle), 8, 39, 10.1089/wound.2019.0946 · DOI
  2. Järbrink, 2017, The humanistic and economic burden of chronic wounds: a protocol for a systematic review, Syst Rev, 6, 15, 10.1186/s13643-016-0400-8 · DOI
  3. Phillips, 2016, Estimating the costs associated with the management of patients with chronic wounds using linked routine data, Int Wound J, 13, 1193, 10.1111/iwj.12443 · DOI
  4. Gardner, 2001, The validity of the clinical signs and symptoms used to identify localized chronic wound infection, Wound Repair Regen, 9, 178, 10.1046/j.1524-475x.2001.00178.x · DOI
  5. 2008, Wound infection in clinical practice. An international consensus, Int Wound J, 5
  6. Grey, 2006, Wound assessment, BMJ, 332, 285, 10.1136/bmj.332.7536.285 · DOI
  7. Falcone, 2021, Diabetes and acute bacterial skin and skin structure infections, Diabetes Res Clin Pract, 174, 10.1016/j.diabres.2021.108732 · DOI
  8. Jaul, 2018, An overview of co-morbidities and the development of pressure ulcers among older adults, BMC Geriatr, 18, 305, 10.1186/s12877-018-0997-7 · DOI
  9. Edwards-Jones, 2020, Antimicrobial stewardship in wound care, Br J Nurs, 29, S10, 10.12968/bjon.2020.29.15.S10 · DOI
  10. Gilmartin, 2003, A holistic approach to wound care, Nurs Times, 99, 64
  11. Tayeb, 2015, Managing infection: a holistic approach, J Wound Care, 24, 20, 10.12968/jowc.2015.24.Sup5b.20 · DOI
  12. Karahan, 2018, Factors affecting wound healing in individuals with pressure ulcers: a retrospective study, Ostomy Wound Manage, 64, 32, 10.25270/owm.2018.2.3239 · DOI
  13. Olin, 2010, Peripheral artery disease: current insight into the disease and its diagnosis and management, Mayo Clin Proc, 85, 678, 10.4065/mcp.2010.0133 · DOI · Paper page
  14. Jiang, 2021, Using machine learning technologies in pressure injury management: systematic review, JMIR Med Inform, 9, e25704, 10.2196/25704 · DOI
  15. Ren, 2020, Strategies and challenges in the treatment of chronic venous leg ulcers, World J Clin Cases, 8, 5070, 10.12998/wjcc.v8.i21.5070 · DOI
  16. Appil, 2020, Effect of family empowerment on HbA1c levels and healing of diabetic foot ulcers, Int J Low Extrem Wounds
  17. Dixon, 2021, Managing diabetic foot ulcers: pharmacotherapy for wound healing, Drugs, 81, 29, 10.1007/s40265-020-01415-8 · DOI
  18. Nickinson, 2020, The utilisation of vascular limb salvage services in the assessment and management of chronic limb-threatening ischaemia and diabetic foot ulceration: a systematic review, Diabetes Metab Res Rev, 10.1002/dmrr.3326 · DOI
  19. Mustoe, 2006, Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis, Plast Reconstr Surg, 117, 35S, 10.1097/01.prs.0000225431.63010.1b · DOI · Paper page
  20. Businaro, 2016, Multidisciplinary approaches to stimulate wound healing, Ann N Y Acad Sci, 1378, 137, 10.1111/nyas.13158 · DOI
  21. Brown-Maher, 2009, Multidisciplinary approach to chronic wound care: our 2-year Newfoundland and Labrador experience, J Cutan Med Surg, 13, S26, 10.2310/7750.2009.00006 · DOI
  22. Werdin, 2009, Evidence-based management strategies for treatment of chronic wounds, Eplasty, 9, e19
  23. Gottrup, 2001, A new concept of a multidisciplinary wound healing center and a national expert function of wound healing, Arch Surg, 136, 765, 10.1001/archsurg.136.7.765 · DOI
  24. Bergendahl, 2020, Development and evaluation of an interprofessional teaching concept for modern wound management, J Dtsch Dermatol Ges, 18, 977
  25. Mahmoudi, 2020, Opportunities and challenges of the management of chronic wounds: a multidisciplinary viewpoint, Chronic Wound Care Management and Research, 7, 27, 10.2147/CWCMR.S260136 · DOI
  26. Bonham, 2009, Swab cultures for diagnosing wound infections: a literature review and clinical guideline, J Wound Ostomy Continence Nurs, 36, 389, 10.1097/WON.0b013e3181aaef7f · DOI
  27. Stevens, 2014, Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America, Clin Infect Dis, 59, 147, 10.1093/cid/ciu444 · DOI · Paper page
  28. Healy, 2006, ABC of wound healing: infections, BMJ, 332, 838, 10.1136/bmj.332.7545.838 · DOI
  29. Bowler, 2003, The 105 bacterial growth guideline: reassessing its clinical relevance in wound healing, Ostomy Wound Manage, 49, 44
  30. Dow, 2003, Bacterial swabs and the chronic wound: when, how, and what do they mean, Ostomy Wound Manage, 49, 8
  31. Cutting, 2004, Defined and refined: criteria for identifying wound infection revisited, Br J Community Nurs, 9, S6, 10.12968/bjcn.2004.9.Sup1.12495 · DOI
  32. Schwarzkopf, 2015, Indications and practical implementation of microbiologic diagnostics in patients with chronic wounds, J Dtsch Dermatol Ges, 13, 203
  33. Stotts, 1995, Determination of bacterial burden in wounds, Adv Wound Care, 8, 28
  34. Kallstrom, 2014, Are quantitative bacterial wound cultures useful?, J Clin Microbiol, 52, 2753, 10.1128/JCM.00522-14 · DOI
  35. Haalboom, 2019, Culture results from wound biopsy versus wound swab: does it matter for the assessment of wound infection?, Clin Microbiol Infect, 25, 629, 10.1016/j.cmi.2018.08.012 · DOI
  36. Alavi, 2010, When and how to perform a biopsy on a chronic wound, Adv Skin Wound Care, 23, 132, 10.1097/01.ASW.0000363515.09394.66 · DOI
  37. Omar, 2017, Microbial biofilms and chronic wounds, Microorganisms, 5, 9, 10.3390/microorganisms5010009 · DOI
  38. Lineback, 2018, Hydrogen peroxide and sodium hypochlorite disinfectants are more effective against Staphylococcus aureus and Pseudomonas aeruginosa biofilms than quaternary ammonium compounds, Antimicrob Resist Infect Control, 7, 154, 10.1186/s13756-018-0447-5 · DOI
  39. Evelhoch, 2020, Biofilm and chronic nonhealing wound infections, Surg Clin North Am, 100, 727, 10.1016/j.suc.2020.05.004 · DOI · Paper page
  40. Ng, 2015, Development of biofilm-targeted antimicrobial wound dressing for the treatment of chronic wound infections, Drug Dev Ind Pharm, 41, 1902, 10.3109/03639045.2015.1019888 · DOI
  41. Harika, 2020, Detection of biofilm production and its impact on antibiotic resistance profile of bacterial isolates from chronic wound infections, J Glob Infect Dis, 12, 129, 10.4103/jgid.jgid_150_19 · DOI
  42. Thieme, 2019, MBEC versus MBIC: the lack of differentiation between biofilm reducing and inhibitory effects as a current problem in biofilm methodology, Biol Proced Online, 21, 18, 10.1186/s12575-019-0106-0 · DOI
  43. Frank, 2007, In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates, Antimicrob Agents Chemother, 51, 888, 10.1128/AAC.01052-06 · DOI
  44. Macià, 2014, Antimicrobial susceptibility testing in biofilm-growing bacteria, Clin Microbiol Infect, 20, 981, 10.1111/1469-0691.12651 · DOI
  45. Bianchi, 2016, Recommendations for the management of biofilm: a consensus document, J Wound Care, 25, 305, 10.12968/jowc.2016.25.6.305 · DOI
  46. Attinger, 2012, Clinically addressing biofilm in chronic wounds, Adv Wound Care (New Rochelle), 1, 127, 10.1089/wound.2011.0333 · DOI
  47. Bekara, 2018, New techniques for wound management: a systematic review of their role in the management of chronic wounds, Arch Plast Surg, 45, 102, 10.5999/aps.2016.02019 · DOI
  48. Schultz, 2003, Wound bed preparation: a systematic approach to wound management, Wound Repair Regen, 11, S1
  49. Harries, 2016, Wound bed preparation: TIME for an update, Int Wound J, 13, 8, 10.1111/iwj.12662 · DOI
  50. Caldwell, 2020, Bacteria and antibiotics in wound healing, Surg Clin North Am, 100, 757, 10.1016/j.suc.2020.05.007 · DOI
  51. Bowler, 2018, Antibiotic resistance and biofilm tolerance: a combined threat in the treatment of chronic infections, J Wound Care, 27, 273, 10.12968/jowc.2018.27.5.273 · DOI
  52. Lipsky, 2009, Topical antimicrobial therapy for treating chronic wounds, Clin Infect Dis, 49, 1541, 10.1086/644732 · DOI
  53. Chrisman, 2010, Care of chronic wounds in palliative care and end-of-life patients, Int Wound J, 7, 214, 10.1111/j.1742-481X.2010.00682.x · DOI
  54. Frank, 2005, Approach to infected skin ulcers, Can Fam Physician, 51, 1352
  55. Uçkay, 2018, A randomized, controlled study to investigate the efficacy and safety of a topical gentamicin–collagen sponge in combination with systemic antibiotic therapy in diabetic patients with a moderate or severe foot ulcer infection, BMC Infect Dis, 18, 361, 10.1186/s12879-018-3253-z · DOI
  56. Kramer, 2018, Consensus on wound antisepsis: update 2018, Skin Pharmacol Physiol, 31, 28, 10.1159/000481545 · DOI
  57. Adkins, 2013, Wound care dressings and choices for care of wounds in the home, Home Healthc Nurse, 31, 259, 10.1097/NHH.0b013e31828eb658 · DOI
  58. Mangoni, 2016, Antimicrobial peptides and wound healing: biological and therapeutic considerations, Exp Dermatol, 25, 167, 10.1111/exd.12929 · DOI
  59. Thapa, 2020, Topical antimicrobial peptide formulations for wound healing: current developments and future prospects, Acta Biomater, 103, 52, 10.1016/j.actbio.2019.12.025 · DOI
  60. Kawano, 2020, Are antimicrobial peptide dendrimers an escape from ESKAPE?, Adv Wound Care (New Rochelle), 9, 378, 10.1089/wound.2019.1113 · DOI
  61. Hernandez, 2006, The use of systemic antibiotics in the treatment of chronic wounds, Dermatol Ther, 19, 326, 10.1111/j.1529-8019.2006.00091.x · DOI
  62. Robson, 1974, The efficacy of systemic antibiotics in the treatment of granulating wounds, J Surg Res, 16, 299, 10.1016/0022-4804(74)90046-8 · DOI
  63. Leaper, 2015, Approach to chronic wound infections, Br J Dermatol, 173, 351, 10.1111/bjd.13677 · DOI
  64. Tiseo, 2019, Identifying patients with acute bacterial skin and skin structure infection who need blood cultures, Intern Emerg Med, 14, 203, 10.1007/s11739-018-02017-9 · DOI
  65. Goh, 2014, Early diagnosis of necrotizing fasciitis, Br J Surg, 101, e119, 10.1002/bjs.9371 · DOI
  66. Jockenhöfer, 2014, W.A.R. scores in patients with chronic leg ulcers: results of a multicentre study, J Wound Care, 23, 5, 10.12968/jowc.2014.23.1.5 · DOI
  67. Campanile, 2012, Changing Italian nosocomial–community trends and heteroresistance in Staphylococcus aureus from bacteremia and endocarditis, Eur J Clin Microbiol Infect Dis, 31, 739, 10.1007/s10096-011-1367-y · DOI
  68. Falcone, 2009, Serious infections due to methicillin-resistant Staphylococcus aureus: an evolving challenge for physicians, Eur J Intern Med, 20, 343, 10.1016/j.ejim.2008.08.016 · DOI
  69. Venditti, 2003, Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case–control study, Haematologica, 88, 923
  70. Reich-Schupke, 2010, Eradication of MRSA in chronic wounds of outpatients with leg ulcers is accelerated by antiseptic washes—results of a pilot study, Int J Hyg Environ Health, 213, 88, 10.1016/j.ijheh.2010.01.001 · DOI
  71. Zafari, 2021, Effects of cefazolin-containing niosome nanoparticles against methicillin-resistant Staphylococcus aureus biofilm formed on chronic wounds, Biomed Mater, 16, 10.1088/1748-605X/abc7f2 · DOI
  72. Allegranzi, 2016, New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective, Lancet Infect Dis, 16, e288, 10.1016/S1473-3099(16)30402-9 · DOI
  73. Roth, 2017, Effect of antiseptic irrigation on infection rates of traumatic soft tissue wounds: a longitudinal cohort study, J Wound Care, 26, 79, 10.12968/jowc.2017.26.3.79 · DOI
  74. Leaper, 2012, Extending the TIME concept: what have we learned in the past 10 years?, Int Wound J, 9, 1, 10.1111/j.1742-481X.2012.01097.x · DOI
  75. Capriotti, 2012, Topical iodophor preparations: chemistry, microbiology, and clinical utility, Dermatol Online J, 18, 1
  76. Liu, 2018, Cytotoxicity evaluation of chlorhexidine gluconate on human fibroblasts, myoblasts, and osteoblasts, J Bone Jt Infect, 3, 165, 10.7150/jbji.26355 · DOI
  77. Hidalgo, 2001, Mechanisms underlying chlorhexidine-induced cytotoxicity, Toxicol In Vitro, 15, 271, 10.1016/S0887-2333(01)00020-0 · DOI
  78. Gonzalez-Espinosa, 2007, Effects of pH-neutral, super-oxidised solution on human dermal fibroblasts in vitro, Int Wound J, 4, 241, 10.1111/j.1742-481X.2007.00331.x · DOI
  79. Severing, 2019, Safety and efficacy profiles of different commercial sodium hypochlorite/hypochlorous acid solutions (NaClO/HClO): antimicrobial efficacy, cytotoxic impact and physicochemical parameters in vitro, J Antimicrob Chemother, 74, 365, 10.1093/jac/dky432 · DOI · Paper page
  80. Cotter, 1985, Chemical parameters, antimicrobial activities, and tissue toxicity of 0.1 and 0.5% sodium hypochlorite solution, Antimicrob Agents Chemother, 28, 118, 10.1128/AAC.28.1.118 · DOI
  81. Cooper, 1991, Hansbrough. The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes, J Trauma, 31, 775, 10.1097/00005373-199106000-00007 · DOI
  82. Sheldon, 2005, Antiseptic ‘resistance’: real or perceived threat?, Clin Infect Dis, 40, 1650, 10.1086/430063 · DOI
  83. Roberts, 2017, The role of topical antiseptic agents within antimicrobial stewardship strategies for prevention and treatment of surgical site and chronic open wound infection, Adv Wound Care (New Rochelle), 6, 63, 10.1089/wound.2016.0701 · DOI
  84. Ortega-Peña, 2017, In vitro microbicidal, anti-biofilm and cytotoxic effects of different commercial antiseptics, Int Wound J, 14, 470, 10.1111/iwj.12625 · DOI
  85. Johani, 2018, Evaluation of short exposure times of antimicrobial wound solutions against microbial biofilms: from in vitro to in vivo, J Antimicrob Chemother, 73, 494, 10.1093/jac/dkx391 · DOI
  86. Falcone, 2020, Role of low-molecular-weight heparin in hospitalized patients with severe acute respiratory syndrome Coronavirus 2 pneumonia: a prospective observational study, Open Forum Infect Dis, 7
  87. Coppelli, 2020, Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the Pisa COVID-19 study., Diabetes Care, 43, 2345, 10.2337/dc20-1380 · DOI
  88. Falcone, 2021, Diabetes and acute bacterial skin and skin structure infections, Diabetes Res Clin Pract., 174

Cited by

Sorted by citations

Metadata

Authors
Falcone, M., De Angelis, B., Pea, F., Scalise, A., Stefani, S., Tasinato, R., Zanetti, O., & Dalla Paola, L.
Venue
Journal of Global Antimicrobial Resistance
Publisher
Elsevier BV
Published
2021-09
Volume
26
Pages
140-147
ISSN
2213-7165
DOI
10.1016/j.jgar.2021.05.010
Cited by
339
References
0
Language
en
Licence
Funders
  • Angelini Pharma
  • Gilead Sciences
  • Nordic Pharma Group
  • Meso Scale Diagnostics
  • Shionogi

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review